The 25 references in paper A. Smirnov V., I. Trofimenko I., A. Shumilina A., O. Ivanov I., V. Sipovsky G., V. Titova A., R. Zverkov V., А. Смирнов В., И. Трофименко И., А. Шумилина А., О. Иванов И., В. Сиповский Г., В. Титова А., Р. Зверьков В. (2010) “БЫСТРОПРОГРЕССИРУЮЩИЙ НЕФРИТИЧЕСКИЙ СИНДРОМ У ПАЦИЕНТКИ С КРИОГЛОБУЛИНЕМИЧЕСКИМ ВАСКУЛИТОМ, АССОЦИИРОВАННЫМ С ХРОНИЧЕСКИМ ВИРУСНЫМ ГЕПАТИТОМ С // RAPIDLY PROGRESSIVE NEPHRITIC SYNDROME IN PATIENTS WITH CRYOGLOBULINEMIC VASCULITIS ASSOCIATED WITH CHRONIC HEPATITIS C” / spz:neicon:nefr:y:2010:i:1:p:104-110

1
Ферри К. Смешанная криоглобулинеми. Нефрология
(check this in PDF content)
2
10; 14 (1) 2. Barry M. Brenner , «Brenner and Rector’s The Kidney» , 8th ed. Saunders 2007, chapter 32
(check this in PDF content)
3
D’Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998; 54: 650-671
(check this in PDF content)
4
Perico N, Cattaneo D, Bikbov, B, Remuzzi G. Hepatitis C Infection and Chronic Renal Diseases. Clin J Am Soc Nephrol 2009; 4: 207-220
(check this in PDF content)
5
Meyers CM, Seeff LB, Stehman-Breen C O, Hoofnagle JH. Hepatitis C and renal disease: an update, American Journal of Kidney Diseases 2003; 42( 4) 631- 657
(check this in PDF content)
6
Tarantino A, Campise M, Banfi G, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995; 47: 618-623
(check this in PDF content)
7
Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-470
(check this in PDF content)
8
Garini G, Allegri L, lannuzzella F, et al. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapie. Acta Biomed 2007; 78: 51-59
(check this in PDF content)
9
Sinico RA, Fornasieri A, D’Amico G. Renal manifestations associated with hepatitis C virus. Ann Med Interne 2000; 151(1): 41-45
(check this in PDF content)
10
Saadoun D, Delluc A, Piette JC, Cacoub P. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis. Current Opinion in Rheumatology 2008; 20: 23-28
(check this in PDF content)
11
Cacoub P, Delluc A, Saadoun D, et al. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand. Ann Rheum Dis 2008; 67: 283­ 287
(check this in PDF content)
12
Милованова СЮ, Лопаткина ТН, Козловская ЛВ, Крас­ нова ТН. Моноклональные антитела к B-лимфоцитам (ри- туксимаб) в лечении HCV-ассоциированного криоглобулинемического гломерулонефрита тяжелого те­ чения. Тер арх 2007; 6: 69-72
(check this in PDF content)
13
Forde KA, Reddy KR. Hepatitis C Virus Infection and Immunomodulatory Therapies. Clinics in Liver Disease 2009; 13(3): 391-401
(check this in PDF content)
14
Fabrizi F, Lunghi G, Messa P, Martin P Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 2008; 21: 813-825
(check this in PDF content)
15
Roccatello D, Fornasieri A, Giachino O, et al. Multicenter Study on Hepatitis C Virus-Related Cryoglobulinemic Glomerulonephritis. Am J Kidney Dis 2007; 49(1): 69-82
(check this in PDF content)
16
Ramos-Casals M, Robles A, Brito-Zeryn P, et al. Life- threatening cryoglobulinemia: clinical and immunological characterization of 29 cases. Semin Arthritis Rheum 2006; 36(3): 189-196
(check this in PDF content)
17
Ahmed MS, Wong CF, Shawki H, et al. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature. Clin Nephrol 2008; 69(4): 298-301
(check this in PDF content)
18
Ohta S, Yokoyama H, Wada T et al. Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. Am J Kidney Dis 1999; 33(6): 1040-1048
(check this in PDF content)
19
Bruchfeld A, Lindahl K, Stеhle L, et al. Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant 2003; 18(8): 1573-1580
(check this in PDF content)
20
McHutchison JG, Manns MP, Brown RS Jr, et al. Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy. Am J Gastroenterol 2007; 102(4): 880-889
(check this in PDF content)
21
Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 49(4): 1335-1374
(check this in PDF content)
22
Rossini A, Ravaggi A, Biasi L et al. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis. Hepatology 1997; 26(4): 1012-1017
(check this in PDF content)
23
Marcellin P, Levy S, Erlinger S. Therapy of hepatitis C: Patients with normal aminotransferase levels. Hepatology 1997; 26[Suppl1]:133S-136S
(check this in PDF content)
24
Jamal MM, Soni A, Quinn PG et al. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the southwestern United States. Hepatology 1999; 30(5): 1307-1311
(check this in PDF content)
25
http: //consensus.nih.gov/2002/ 2002HepatitisC2002116html.htm Поступила в редакцию 09.02.2010 г. Принята в печать 02.03.2010 г.
(check this in PDF content)